Howard Hughes Medical Institute’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.2M Buy
322,105
+316,884
+6,069% +$58.1M 13.51% 2
2025
Q4
$974K Sell
5,221
-19
-0.4% -$3.54K 0.56% 2
2025
Q3
$978K Sell
5,240
-45
-0.9% -$7.84K 0.57% 2
2025
Q2
$835K Buy
+5,285
New +$665K 0.33% 2

Other funds holding NVDA

Howard Hughes Medical Institute's NVDA Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its NVIDIA (NVDA) stake by 6,069% in Q1 2026, buying an estimated $58.1M and bringing the position to 322,105 shares worth $56.2M. The position accounts for 13.51% of the portfolio, ranked #2.

Howard Hughes Medical Institute first reported a position in NVDA in Q2 2025 and has held it in 4 quarters since. 5,832 funds tracked by Wall St. Rank hold NVDA as of Q1 2026.

  • Howard Hughes Medical Institute held 322,105 shares of NVIDIA worth $56.2M as of Q1 2026.
  • Howard Hughes Medical Institute bought 316,884 NVIDIA shares in Q1 2026, an estimated $58.1M.
  • NVIDIA made up 13.51% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #2 holding.
  • Howard Hughes Medical Institute first reported a position in NVIDIA in Q2 2025 and has held it in 4 quarters since.
  • 5,832 funds tracked by Wall St. Rank held NVIDIA as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.